Javanbakht, Marjan
Lin, Johnny
Ragsdale, Amy
Kim, Soyeon
Siminski, Suzanne
Gorbach, Pamina
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA036267, U01DA036267, U01DA036267, U01DA036267, U01DA036267, U01DA036267)
Article History
Received: 4 August 2021
Accepted: 24 February 2022
First Online: 3 April 2022
Declarations
:
: The study was carried out in accordance with relevant guidelines and regulations governing human subject research. Specifically, the University of California Los Angeles (UCLA) holds Federal Wide Assurance (FWA number 00004642), which assures that it will meet all the requirements of Title 45, Part 46 of the Code of Federal Regulations (45 CFR 46) for all human subjects research. The study was approved by the UCLA Institutional Review Board IRB#18–000876. All participants provided written informed consent prior to study participation.
: Not applicable.
: The authors declare that they have no competing interests.